Interferon-gamma protects human endothelial cells from lymphokine-activated killer cell-mediated lysis
- 1 November 1988
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 18 (11), 1839-1842
- https://doi.org/10.1002/eji.1830181129
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection.The Journal of Experimental Medicine, 1987
- Therapeutic potential of cytokinesClinical Immunology Newsletter, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Endothelial cell lysis induced by lymphokine‐activated human peripheral blood mononuclear cellsEuropean Journal of Immunology, 1987
- Induction of the expression of HLA class I antigens on K562 by interferons and sodium butyrateHuman Immunology, 1985
- Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.The Journal of Experimental Medicine, 1983
- Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.The Journal of Experimental Medicine, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Human Pulmonary Endothelial Cells in CultureJCI Insight, 1980
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJCI Insight, 1973